Overexpression of mitotic kinesins, which are postulated to work by countering the microtubule-stabilizing effect of taxane-based chemotherapy, has been linked to docetaxel resistance in breast cancer [20], and MCAK overexpression has been causally related to paclitaxel resistance [21]. Here, KIF2C is linked to breast carcinoma.